Mouse models for studying genetic influences on factors determining smoking cessation success in humans

Annals of the New York Academy of Sciences

Volumn 1248, Issue 1, 2012, Pages 39-70

  Hall, F Scott ^a   Markou, Athina ^b   Levin, Edward D ^c   Uhl, George R ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Genetics; Nicotine; Quit success; Smoking cessation

Indexed keywords

NICOTINE;

ABSTINENCE; ANXIETY; COGNITION; DISEASE ASSOCIATION; DISEASE EXACERBATION; DYSPHORIA; HABIT; HEREDITY; HUMAN; LEARNING; MEMORY DISORDER; MOLECULAR GENETICS; NONHUMAN; REVIEW; SMOKING; SMOKING CESSATION; WEIGHT GAIN; WITHDRAWAL SYNDROME;

MUS; NICOTIANA TABACUM;

EID: 84856565851     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2011.06415.x     Document Type: Review

References (329)

1. Broms, U. et al. 2006. Genetic architecture of smoking behavior: a study of Finnish adult twins. Twin. Res. Hum. Genet. 9: 64-72.
2. Morley, K.I. et al. 2007. Exploring the inter-relationship of smoking age-at-onset, cigarette consumption and smoking persistence: genes or environment? Psychol. Med. 37: 1357-1367.
3. Uhl, G.R. et al. 2008. Molecular genetics of addiction and related heritable phenotypes: genome-wide association approaches identify "connectivity constellation" and drug target genes with pleiotropic effects. Ann. N. Y. Acad. Sci. 1141: 318-381.
4. Uhl, G.R. et al. 2008. "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem. Pharmacol. 75: 98-111.
5. Uhl, G.R. et al. 2010. Vulnerability to substance abuse. In Addiction Medicine: Science and Practice. B.A. Johnson, Ed.: 201-224. Springer. Heidelberg. Germany.
6. Uhl, G.R. et al. 1995. Genetic influences in drug abuse. In Psychopharmacology: The Fourth Generation of Progress. F.E. Gloom & D.J. Kupfer, Eds.: 1793-2783. Raven Press. New York.
7. Kendler, K.S. et al. 2000. Illicit psychoactive substance use, heavy use, abuse, and dependence in a US population-based sample of male twins. Arch. Gen. Psychiatry 57: 261-269.
8. Uhl, G.R. et al. 2010. Genome-wide association for smoking cessation success in a trial of precessation nicotine replacement. Mol. Med. 16(11-12): 513-526.
9. Uhl, G.R. et al. 2010. Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement. Pharmacogenomics 11(3): 357-367.
10. Uhl, G.R. et al. 2008. Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch. Gen. Psychiatry 65(3): 345-355.
11. Uhl, G.R. et al. 2007. Molecular genetics of nicotine dependence and abstinence: whole genome association using 520, 000 SNPs. BMC Genet. 8: 10.
12. Johnson, C. et al. 2008. Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples. BMC Med. Genet. 9: 113.
13. Johnson, C., T. Drgon, D. Walther & G.R. Uhl. 2011. Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependence. PLoS One 6(7): e19210.
14. Drgon, T. et al. 2009. Genome-wide association for smoking cessation success: participants in a trial with adjunctive denicotinized cigarettes. Mol. Med. 15(7-8): 268-274.
15. Drgon, T. et al. 2010. "Replicated" genome wide association for dependence on illegal substances: genomic regions identified by overlapping clusters of nominally positive SNPs. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 156B(2): 125-138.
16. Drgon, T. et al. 2009. Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. Mol. Med. 15(1-2): 21-27.
17. Drgon, T. et al. 2010. Genome wide association for addiction: replicated results and comparisons of two analytic approaches. PLoS One 5(1): e8832.
18. Uhl, G.R. et al. 2008. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Arch. Gen. Psychiatry 65(6): 683-693.
19. Hughes, J.R. 2007. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob. Res. 9: 315-327.
20. Hughes, J.R. & M.J. Carpenter. 2005. The feasibility of smoking reduction: an update. Addiction 100: 1074-1089.
21. Cosgrove, K.P. et al. 2010. Beta2* nicotinic acetylcholine receptors modulate pain sensitivity in acutely abstinent tobacco smokers. Nicotine Tob. Res. 12: 535-539.
22. Bouchard, T.J., Jr. 2009. Genetic influence on human intelligence (Spearman's g): how much? Ann. Hum. Biol. 36: 527-544.
23. Jacobsen, L.K. et al. 2009. Allelic variation of calsyntenin 2 (CLSTN2) modulates the impact of developmental tobacco smoke exposure on mnemonic processing in adolescents. Biol. Psychiatry 65: 671-679.
24. Patterson, F. et al. 2010. Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend. 106: 61-64.
25. Levin, E.D., F.J. McClernon & A.H. Rezvani. 2006. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl). 184: 523-539.
26. Herman, A.I. & M. Sofuoglu. 2010. Cognitive effects of nicotine: genetic moderators. Addict. Biol. 15: 250-265.
27. Cincotta, S.L. et al. 2008. Selective nicotinic acetylcholine receptor agonists: potential therapies for neuropsychiatric disorders with cognitive dysfunction. Curr. Opin. Investig. Drugs 9: 47-56.
28. Hatsukami, D. et al. 1989. The effects of varying cigarette deprivation duration on cognitive and performance tasks. J. Subst. Abuse. 1: 407-416.
29. George, T.P. et al. 2002. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacol. 26: 75-85.
30. Sacco, K.A. et al. 2005. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch. Gen. Psychiatry 62: 649-659.
31. Loughead, J. et al. 2010. Effects of the α4β2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol. Psychiatry 67: 715-721.
32. de Leon, J. et al. 1995. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am. J. Psychiatry 152: 453-455.
33. Elvevag, B. & T.E. Goldberg. 2000. Cognitive impairment in schizophrenia is the core of the disorder. Crit. Rev. Neurobiol. 14: 1-21.
34. Keefe, R.S. et al. 1992. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Res. 44: 153-165.
35. Park, S. & P.S. Holzman. 1992. Schizophrenics show spatial working memory deficits. Arch. Gen. Psychiatry 49: 975-982.
36. Aleman, A. et al. 1999. Memory impairment in schizophrenia: a meta-analysis. Am. J. Psychiatry 156: 1358-1366.
37. Olincy, A. & K.E. Stevens. 2007. Treating schizophrenia symptoms with an α7 nicotinic agonist, from mice to men. Biochem. Pharmacol. 74: 1192-1201.
38. Adler, L.E. et al. 1993. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am. J. Psychiatry 150: 1856-1861.
39. Kumari, V., W. Soni & T. Sharma. 2001. Influence of cigarette smoking on prepulse inhibition of the acoustic startle response in schizophrenia. Hum. Psychopharmacol. 16: 321-326.
40. George, T.P. et al. 2006. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophr. Res. 87: 307-315.
41. Freedman, R. et al. 1994. Schizophrenia and nicotinic receptors. Harv. Rev. Psychiatry 2: 179-192.
42. Freedman, R. et al. 1997. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc. Natl. Acad. Sci. U. S. A. 94: 587-592.
43. Leonard, S. et al. 2002. Association of promoter variants in the α7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia. Arch. Gen. Psychiatry 59: 1085-1096.
44. Freedman, R. et al. 1995. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol. Psychiatry 38: 22-33.
45. Marutle, A. et al. 2001. Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia. J. Chem. Neuroanat. 22: 115-126.
46. Levin, E.D. et al. 1996. Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacol. 15: 429-436.
47. D'Souza, M.S. & A. Markou. 2011. Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits. Neuropharmacology. Available at:. Access date 18 January 2012.
48. Jubelt, L.E. et al. 2008. Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia. Psychopharmacology (Berl). 199: 89-98.
49. Di Chiara, G. 2000. Role of dopamine in the behavioural actions of nicotine related to addiction. Eur. J. Pharmacol. 393: 295-314.
50. Paolini, M. & M. De Biasi. 2011. Mechanistic insights into nicotine withdrawal. Biochem. Pharmacol. 82: 996-1007.
51. Shiffman, S.M. & M.E. Jarvik. 1976. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology (Berl). 50: 35-39.
52. Heishman, S.J., R.C. Taylor & J.E. Henningfield. 1994. Nicotine and smoking: a review of effects on nicotine performance. Exp. Clin. Psychopharmacol. 2: 345-395.
53. Heishman, S.J., B.A. Kleykamp & E.G. Singleton. 2010. Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl). 210: 453-469.
54. Myers, C.S. et al. 2008. Dose-related enhancement of mood and cognition in smokers administered nicotine nasal spray. Neuropsychopharmacol. 33: 588-598.
55. Gross, T.M., M.E. Jarvik & M.R. Rosenblatt. 1993. Nicotine abstinence produces content-specific Stroop interference. Psychopharmacology (Berl). 110: 333-336.
56. Keenan, R.M., D.K. Hatsukami & D.J. Anton. 1989. The effects of short-term smokeless tobacco deprivation on performance. Psychopharmacology (Berl). 98: 126-130.
57. Hughes, J.R., R.M. Keenan & A. Yellin. 1989. Effect of tobacco withdrawal on sustained attention. Addict. Behav. 14: 577-580.
58. Sweet, L.H. et al. 2010. Effects of nicotine withdrawal on verbal working memory and associated brain response. Psychiatry Res. 183: 69-74.
59. Snyder, F.R., F.C. Davis & J.E. Henningfield. 1989. The tobacco withdrawal syndrome: performance decrements assessed on a computerized test battery. Drug Alcohol Depend. 23: 259-266.
60. Snyder, F.R. & J.E. Henningfield. 1989. Effects of nicotine administration following 12 h of tobacco deprivation: assessment on computerized performance tasks. Psychopharmacology (Berl). 97: 17-22.
61. Atzori, G. et al. 2008. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal. J. Clin. Psychopharmacol. 28: 667-674.
62. Froeliger, B., D.G. Gilbert & F.J. McClernon. 2009. Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers. Psychopharmacology (Berl). 205: 625-633.
63. Childress, A.R. et al. 1993. Cue reactivity and cue reactivity interventions in drug dependence. NIDA Res. Monogr. 137: 73-95.
64. Collins, B.N., U.S. Nair & E. Komaroff. 2011. Smoking cue reactivity across massed extinction trials: negative affect and gender effects. Addict. Behav. 36: 308-314.
65. Van Gucht, D. et al. 2010. Smoking behavior in context: where and when do people smoke? J. Behav. Ther. Exp. Psychiatry 41: 172-177.
66. McClernon, F.J., R.V. Kozink & J.E. Rose. 2008. Individual differences in nicotine dependence, withdrawal symptoms, and sex predict transient fMRI-BOLD responses to smoking cues. Neuropsychopharmacol. 33: 2148-2157.
67. McClernon, F.J. et al. 2007. Selectively reduced responses to smoking cues in amygdala following extinction-based smoking cessation: results of a preliminary functional magnetic resonance imaging study. Addict. Biol. 12: 503-512.
68. Beckham, J.C. et al. 2007. The effects of cigarette smoking on script-driven imagery in smokers with and without posttraumatic stress disorder. Addict. Behav. 32: 2900-2915.
69. Santa Ana, E.J. et al. 2009. D-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation. Drug Alcohol Depend. 104: 220-227.
70. Schneider, N.G., M.E. Jarvik & A.B. Forsythe. 1984. Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation. Addict. Behav. 9: 149-156.
71. Hutchison, K.E. et al. 1999. Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results. Psychopharmacology (Berl). 142: 139-143.
72. Geier, A., R.F. Mucha & P. Pauli. 2000. Appetitive nature of drug cues confirmed with physiological measures in a model using pictures of smoking. Psychopharmacology (Berl). 150: 283-291.
73. Waters, A.J. et al. 2003. Attentional shifts to smoking cues in smokers. Addiction 98: 1409-1417.
74. Robinson, T.E. & K.C. Berridge. 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18: 247-291.
75. Mogg, K., M. Field & B.P. Bradley. 2005. Attentional and approach biases for smoking cues in smokers: an investigation of competing theoretical views of addiction. Psychopharmacology (Berl). 180: 333-341.
76. Erblich, J. et al. 2005. Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers. Mol. Psychiatry 10: 407-414.
77. Colamussi, L., D.H. Bovbjerg & J. Erblich. 2007. Stress- and cue-induced cigarette craving: effects of a family history of smoking. Drug Alcohol Depend. 88: 251-258.
78. McClernon, F.J. et al. 2005. Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues. Neuropsychopharmacol. 30: 1940-1947.
79. Smolka, M.N. et al. 2006. Severity of nicotine dependence modulates cue-induced brain activity in regions involved in motor preparation and imagery. Psychopharmacology (Berl). 184: 577-588.
80. David, S.P. et al. 2007. Effects of acute nicotine abstinence on cue-elicited ventral striatum/nucleus accumbens activation in female cigarette smokers: a functional magnetic resonance imaging study. Brain Imaging Behav. 1: 43-57.
81. McBride, D. et al. 2006. Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study. Neuropsychopharmacol. 31: 2728-2738.
82. Franklin, T.R. et al. 2007. Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study. Neuropsychopharmacol. 32: 2301-2309.
83. Shiffman, S. et al. 2003. Efficacy of acute administration of nicotine gum in relief of cue-provoked cigarette craving. Psychopharmacology (Berl). 166: 343-350.
84. Doran, N., B. Spring & D. McChargue. 2007. Effect of impulsivity on craving and behavioral reactivity to smoking cues. Psychopharmacology (Berl). 194: 279-288.
85. Field, M. et al. 2007. The smoking Stroop and delay discounting in smokers: effects of environmental smoking cues. J. Psychopharmacol. 21: 603-610.
86. Wang, Z. et al. 2007. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J. Neurosci. 27: 14035-14040.
87. Belin, D. et al. 2008. High impulsivity predicts the switch to compulsive cocaine-taking. Science 320: 1352-1355.
88. Franklin, T.R. et al. 2009. DAT genotype modulates brain and behavioral responses elicited by cigarette cues. Neuropsychopharmacol. 34: 717-728.
89. Limosin, F. et al. 2003. Impulsiveness as the intermediate link between the dopamine receptor D2 gene and alcohol dependence. Psychiatr. Genet. 13: 127-129.
90. Tarantino, I.S. et al. 2011. Working memory span capacity improved by a D2 but not D1 receptor family agonist. Behav. Brain Res. 219: 181-188.
91. Afifi, T.O. et al. 2010. The role of genes and environment on trauma exposure and posttraumatic stress disorder symptoms: a review of twin studies. Clin. Psychol. Rev. 30: 101-112.
92. Pickens, C.L. et al. 2011. Neurobiology of the incubation of drug craving. Trends Neurosci. 34: 411-420.
93. Gawin, F.H. & H.D. Kleber. 1986. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch. Gen. Psychiatry 43: 107-113.
94. Velicer, W.F. et al. 1992. Assessing outcome in smoking cessation studies. Psychol. Bull. 111: 23-41.
95. Silventoinen, K. & J. Kaprio. 2009. Genetics of tracking of body mass index from birth to late middle age: evidence from twin and family studies. Obes. Facts 2: 196-202.
96. Zheng, H. et al. 2009. Appetite control and energy balance regulation in the modern world: reward-driven brain overrides repletion signals. Int. J. Obes (Lond). 33(Suppl. 2): S8-S13.
97. Levine, M.D., K.A. Perkins & M.D. Marcus. 2001. The characteristics of women smokers concerned about postcessation weight gain. Addict. Behav. 26: 749-756.
98. Levine, M.D. et al. 2010. Bupropion and cognitive behavioral therapy for weight-concerned women smokers. Arch. Intern. Med. 170: 543-550.
99. Jessen, A.B., S. Toubro & A. Astrup. 2003. Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilization in men. Am. J. Clin. Nutr. 77: 1442-1447.
100. Okun, M.L. et al. 2011. Subjective sleep disturbance during a smoking cessation program: associations with relapse. Addict. Behav. 36: 861-864.
101. Roberts, M.E. et al. 2008. Association between trauma exposure and smoking in a population-based sample of young adults. J. Adolesc. Health 42: 266-274.
102. Levin, E.D. et al. 1991. The effects of smoking-related sensory cues on psychological stress. Pharmacol. Biochem. Behav. 39: 265-268.
103. Anokhin, A.P. et al. 2011. Heritability of delay discounting in adolescence: a longitudinal twin study. Behav. Genet. 41: 175-183.
104. Winterer, G. 2010. Why do patients with schizophrenia smoke? Curr. Opin. Psychiatry 23: 112-119.
105. Glassman, A.H. 1998. Psychiatry and cigarettes. Arch. Gen. Psychiatr. 55: 692-693.
106. Breslau, N., M. Kilbey & P. Andreski. 1991. Nicotine dependence, major depression, and anxiety in young adults. Arch. Gen. Psychiatry 48: 1069-1074.
107. Glassman, A.H. et al. 1988. Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA 259: 2863-2866.
108. Covey, L.S., A.H. Glassman & F. Stetner. 1997. Major depression following smoking cessation. Am. J. Psychiatry 154: 263-265.
109. Miller, E.N. et al. 1995. Hemispheric asymmetries of function in patients with major affective disorders. J. Psychiatr. Res. 29: 173-183.
110. Carlson, J.M. et al. 2009. Serotonin transporter genotype and depressive symptoms moderate effects of nicotine on spatial working memory. Exp. Clin. Psychopharmacol. 17: 173-180.
111. McClernon, F.J. & S.H. Kollins. 2008. ADHD and smoking: from genes to brain to behavior. Ann. N. Y. Acad. Sci. 1141: 131-147.
112. Hartsough, C.S. & N.M. Lambert. 1987. Pattern and progression of drug use among hyperactives and controls: a prospective short-term longitudinal study. J. Child. Psychol. Psychiatry 28: 543-553.
113. Pomerleau, O.F. et al. 1995. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J. Subst. Abuse 7: 373-378.
114. Fuemmeler, B.F., S.H. Kollins & F.J. McClernon. 2007. Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood. J. Pediatr. Psychol. 32: 1203-1213.
115. Pettiford, J. et al. 2007. Increases in impulsivity following smoking abstinence are related to baseline nicotine intake and boredom susceptibility. Addict. Behav. 32: 2351-2357.
116. Kollins, S.H., F.J. McClernon & J.N. Epstein. 2009. Effects of smoking abstinence on reaction time variability in smokers with and without ADHD: an ex-Gaussian analysis. Drug Alcohol Depend. 100: 169-172.
117. McClernon, F.J. et al. 2008. Interactions between genotype and retrospective ADHD symptoms predict lifetime smoking risk in a sample of young adults. Nicotine Tob. Res. 10: 117-127.
118. Rose, J.E. et al. 2010. Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score. Mol. Med. 16: 247-253.
119. David, S.P. et al. 2010. Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans. Nicotine Tob. Res. 12: 251-262.
120. Uhl, G.R. 2009. Promise of pharmacogenomics in smoking cessation. Pharmacogenomics 10: 1123-1125.
121. Uhl, G.R. et al. 2009. Smoking and smoking cessation in disadvantaged women: assessing genetic contributions. Drug Alcohol Depend. 104(Suppl. 1): S58-S63.
122. Uhl, G.R. et al. 2009. Nicotine abstinence genotyping: assessing the impact on smoking cessation clinical trials. Pharmacogenomics J. 9: 111-115.
123. Munafo, M.R. et al. 2011. CHRNA3 rs1051730 genotype and short-term smoking cessation. Nicotine Tob. Res. 13: 982-988.
124. Leventhal, A.M. et al. 2010. Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. Pharmacogenomics J. doi:.
125. D'Souza, M.S. & A. Markou. 2011. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict. Sci. Clin. Pract. 6: 4-16.
126. Markou, A. 2008. Review. Neurobiology of nicotine dependence. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363: 3159-3168.
127. Stoker, A.K., S. Semenova & A. Markou. 2008. Affective and somatic aspects of spontaneous and precipitated nicotine withdrawal in C57BL/6J and BALB/cByJ mice. Neuropharmacology 54: 1223-1232.
128. Jackson, K.J. et al. 2009. The role of α6-containing nicotinic acetylcholine receptors in nicotine reward and withdrawal. J. Pharmacol. Exp. Ther. 331: 547-554.
129. Tribollet, E., D. Bertrand & M. Raggenbass. 2001. Role of neuronal nicotinic receptors in the transmission and processing of information in neurons of the central nervous system. Pharmacol. Biochem. Behav. 70: 457-466.
130. Marks, M.J. & A.C. Collins. 1985. Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine. Pharmacol. Biochem. Behav. 22: 283-291.
131. Marks, M.J., J.A. Stitzel & A.C. Collins. 1986. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains. J. Pharmacol. Exp. Ther. 239: 358-364.
132. Marks, M.J. et al. 1986. Nicotine-induced tolerance and receptor changes in four mouse strains. J. Pharmacol. Exp. Ther. 237: 809-819.
133. Naylor, C. et al. 2005. Tolerance to nicotine in mice lacking α7 nicotinic receptors. Psychopharmacology (Berl). 180: 558-563.
134. McCallum, S.E. et al. 2006. Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation. Psychopharmacology (Berl). 184: 314-327.
135. Salas, R. et al. 2007. Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the α7 nicotinic acetylcholine receptor subunit. Neuropharmacology 53: 863-869.
136. Stoker, A.K., B. Olivier & A. Markou. 2011. Role of α7- and α4-containing nicotinic acetylcholine receptors in the affective and somatic aspects of nicotine withdrawal: studies in knockout mice. Behav. Genet. doi:.
137. Watkins, S.S. et al. 2000. Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects. J. Pharmacol. Exp. Ther. 292: 1053-1064.
138. Berrendero, F. et al. 2005. Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J. Neurosci. 25: 1103-1112.
139. Jackson, K.J. et al. 2010. Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse. Psychopharmacology (Berl). 210: 285-294.
140. Johnson, P.M., J.A. Hollander & P.J. Kenny. 2008. Decreased brain reward function during nicotine withdrawal in C57BL6 mice: evidence from intracranial self-stimulation (ICSS) studies. Pharmacol. Biochem. Behav. 90: 409-415.
141. Fagerstrom, K.O. & N.G. Schneider. 1989. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J. Behav. Med. 12: 159-182.
142. DiFranza, J. et al. 2010. A systematic review of the Diagnostic and Statistical Manual diagnostic criteria for nicotine dependence. Addict. Behav. 35: 373-382.
143. Fagerstrom, K.O. & N.G. Schneider. 1989. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J. Behav. Med. 12: 159-182.
144. DiFranza, J. et al. 2010. A systematic review of the Diagnostic and Statistical Manual diagnostic criteria for nicotine dependence. Addict. Behav. 35: 373-382.
145. Wise, R.A. & M.A. Bozarth. 1987. A psychomotor stimulant theory of addiction. Psychol. Rev. 94: 469-492.
146. Marks, M.J. et al. 1985. A test battery for measuring nicotine effects in mice. Pharmacol. Biochem. Behav. 23: 325-330.
147. Hart, C. et al. 1996. Effects of the calcium channel blocker nimodipine on nicotine-induced locomotion in rats. Psychopharmacology (Berl). 128: 359-361.
148. Robinson, S.F. et al. 1996. Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice. Pharmacol. Biochem. Behav. 54: 587-593.
149. Biala, G. 2003. Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents. Pol. J. Pharmacol. 55: 327-335.
150. Sahraei, H. et al. 2007. Ascorbic acid antagonizes nicotine-induced place preference and behavioral sensitization in mice. Eur. J. Pharmacol. 560: 42-48.
151. Schechter, M.D., S.M. Meehan & J.B. Schechter. 1995. Genetic selection for nicotine activity in mice correlates with conditioned place preference. Eur. J. Pharmacol. 279: 59-64. [orphan].
152. Yoo, J.H. et al. 2004. Loss of nicotine-induced behavioral sensitization in micro-opioid receptor knockout mice. Synapse 51: 219-223.
153. Kotagale, N.R. et al. 2010. Repeated agmatine treatment attenuates nicotine sensitization in mice: modulation by α2-adrenoceptors. Behav. Brain Res. 213: 161-174.
154. Marks, M.J., J.A. Stitzel & A.C. Collins. 1989. Genetic influences on nicotine responses. Pharmacol. Biochem. Behav. 33: 667-678.
155. Marks, M.J. et al. 1989. Variation of nicotinic binding sites among inbred strains. Pharmacol. Biochem. Behav. 33: 679-689.
156. Sakoori, K. & N.P. Murphy. 2009. Enhanced nicotine sensitivity in nociceptin/orphanin FQ receptor knockout mice. Neuropharmacology 56: 896-904.
157. Sparks, J.A. & J.R. Pauly. 1999. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice. Psychopharmacology (Berl). 141: 145-153.
158. Adriani, W. et al. 2004. Behavioral and neurochemical vulnerability during adolescence in mice: studies with nicotine. Neuropsychopharmacol. 29: 869-878.
159. Kim, H.S., K.S. Kim & K.W. Oh. 1999. Ginseng total saponin inhibits nicotine-induced hyperactivity and conditioned place preference in mice. J. Ethnopharmacol. 66: 83-90.
160. Mineur, Y.S. et al. 2009. Localized low-level re-expression of high-affinity mesolimbic nicotinic acetylcholine receptors restores nicotine-induced locomotion but not place conditioning. Genes. Brain Behav. 8: 257-266.
161. King, S.L., B.J. Caldarone & M.R. Picciotto. 2004. β2-subunit-containing nicotinic acetylcholine receptors are critical for dopamine-dependent locomotor activation following repeated nicotine administration. Neuropharmacology 47(Suppl. 1): 132-139.
162. Cao, W. et al. 1993. A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacol. Biochem. Behav. 45: 803-809.
163. Brioni, J.D. et al. 1993. Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. Eur. J. Pharmacol. 238: 1-8.
164. Petersen, D.R., K.J. Norris & J.A. Thompson. 1984. A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice. Drug Metab. Dispos. 12: 725-731.
165. Marks, M.J. et al. 2004. Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology 46: 1141-1157.
166. Blokhina, E.A. et al. 2005. Effects of nicotinic and NMDA receptor channel blockers on intravenous cocaine and nicotine self-administration in mice. Eur. Neuropsychopharmacol. 15: 219-225.
167. Contet, C. et al. 2010. Patterns of responding differentiate intravenous nicotine self-administration from responding for a visual stimulus in C57BL/6J mice. Psychopharmacology (Berl). 212: 283-299.
168. Rasmussen, T. & M.D. Swedberg. 1998. Reinforcing effects of nicotinic compounds: intravenous self-administration in drug-naive mice. Pharmacol. Biochem. Behav. 60: 567-573.
169. Martellotta, M.C. et al. 1995. Isradipine inhibits nicotine intravenous self-administration in drug-naive mice. Pharmacol. Biochem. Behav. 52: 271-274.
170. Paterson, N.E. et al. 2003. The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice. Psychopharmacology (Berl). 167: 257-264.
171. Picciotto, M.R. et al. 1998. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 391: 173-177.
172. Fowler, C.D. & P.J. Kenny. 2011. Intravenous nicotine self-administration and cue-induced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training. Neuropharmacology 61: 687-698.
173. Galeote, L. et al. 2009. Prodynorphin gene disruption increases the sensitivity to nicotine self-administration in mice. Int. J. Neuropsychopharmacol. 12: 615-625.
174. Thomsen, M. et al. 2009. Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J. Neurosci. 29: 1087-1092.
175. Fowler, C.D. et al. 2011. Habenular α5 nicotinic receptor subunit signalling controls nicotine intake. Nature 471: 597-601.
176. Spiller, K. et al. 2009. Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of α4β2 nicotinic receptors in rats. Neuropharmacology 57: 60-66.
177. Maskos, U. et al. 2005. Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature 436: 103-107.
178. Exley, R. et al. 2011. Distinct contributions of nicotinic acetylcholine receptor subunit α4 and subunit α6 to the reinforcing effects of nicotine. Proc. Natl. Acad. Sci. U. S. A. 108: 7577-7582.
179. David, V. et al. 2006. Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors. Neuropharmacology 50: 1030-1040.
180. Dalley, J.W. et al. 2007. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 315: 1267-1270.
181. Meliska, C.J. et al. 1995. Ethanol, nicotine, amphetamine, and aspartame consumption and preferences in C57BL/6 and DBA/2 mice. Pharmacol. Biochem. Behav. 50: 619-626.
182. Robinson, S.F., M.J. Marks & A.C. Collins. 1996. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl). 124: 332-339.
183. Lee, M. et al. 2004. MAO-B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake. Genes Brain Behav. 3: 216-227.
184. Agatsuma, S. et al. 2006. Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Hum. Mol. Genet. 15: 2721-2731.
185. Zhu, H. et al. 2007. Pleiotropic impact of constitutive fosB inactivation on nicotine-induced behavioral alterations and stress-related traits in mice. Hum. Mol. Genet. 16: 820-836.
186. Glatt, A.R., K. Denton & J.D. Boughter, Jr. 2009. Variation in nicotine consumption in inbred mice is not linked to orosensory ability. Chem. Senses 34: 27-35.
187. Levin, E.D. et al. 2009. Nicotinic α7- or β2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. Behav. Brain Res. 196: 207-213.
188. Wilking, J.A. et al. 2010. Chrna4 A529 knock-in mice exhibit altered nicotine sensitivity. Pharmacogenet. Genomics 20: 121-130.
189. Rowell, P.P. et al. 1983. Oral administration of nicotine: its uptake and distribution after chronic administration to mice. J. Pharmacol. Methods 9: 249-261.
190. Pekonen, K. et al. 1993. Plasma nicotine and cotinine concentrations in mice after chronic oral nicotine administration and challenge doses. Eur. J. Pharm. Sci. 1: 13-18.
191. Tammimaki, A. et al. 2008. Effect of forced chronic oral nicotine exposure on intravenous self-administration and rewarding properties of acute nicotine. Eur. J. Pharmacol. 591: 164-170.
192. Picciotto, M.R. 2003. Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci. 24: 493-499.
193. Scott, D. & N. Hiroi. 2011. Deconstructing craving: dissociable cortical control of cue reactivity in nicotine addiction. Biol. Psychiatry 69: 1052-1059.
194. Tzschentke, T.M. 1998. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol. 56: 613-672.
195. Risinger, F.O. & R.A. Oakes. 1995. Nicotine-induced conditioned place preference and conditioned place aversion in mice. Pharmacol. Biochem. Behav. 51: 457-461.
196. Brielmaier, J.M., C.G. McDonald & R.F. Smith. 2008. Nicotine place preference in a biased conditioned place preference design. Pharmacol. Biochem. Behav. 89: 94-100.
197. Grabus, S.D. et al. 2006. Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology (Berl). 184: 456-463.
198. Kota, D. et al. 2011. Exploring behavioral and molecular mechanisms of nicotine reward in adolescent mice. Biochem. Pharmacol. 82: 1008-1014.
199. Martin, J.L. & Y. Itzhak. 2000. 7-Nitroindazole blocks nicotine-induced conditioned place preference but not LiCl-induced conditioned place aversion. Neuroreport 11: 947-949.
200. Berrendero, F., B.L. Kieffer & R. Maldonado. 2002. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J. Neurosci. 22: 10935-10940.
201. Zarrindast, M.R. et al. 2003. Cross-tolerance between morphine- and nicotine-induced conditioned place preference in mice. Pharmacol. Biochem. Behav. 74: 363-369.
202. Jackson, K.J. et al. 2009. Characterization of pharmacological and behavioral differences to nicotine in C57Bl/6 and DBA/2 mice. Neuropharmacology 57: 347-355.
203. Isiegas, C., S.D. Mague & J.A. Blendy. 2009. Sex differences in response to nicotine in C57Bl/6:129SvEv mice. Nicotine Tob. Res. 11: 851-858.
204. Walters, C.L. et al. 2005. Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron 46: 933-943.
205. Walters, C.L. et al. 2006. The β2 but not α7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl). 184: 339-344.
206. Wang, L.P. et al. 2010. Conditional knockout of NMDA receptors in dopamine neurons prevents nicotine-conditioned place preference. PLoS One 5: e8616.
207. Jackson, K.J. et al. 2010. Role of α5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice. J. Pharmacol. Exp. Ther. 334: 137-146.
208. Gommans, J., I.P. Stolerman & M. Shoaib. 2000. Antagonism of the discriminative and aversive stimulus properties of nicotine in C57BL/6J mice. Neuropharmacology 39: 2840-2847.
209. Castane, A. et al. 2006. Attenuation of nicotine-induced rewarding effects in A2A knockout mice. Neuropharmacology 51: 631-640.
210. Rauhut, A.S., M. Hawrylak & S.K. Mardekian. 2008. Bupropion differentially alters the aversive, locomotor and rewarding properties of nicotine in CD-1 mice. Pharmacol. Biochem. Behav. 90: 598-607.
211. Miner, L.L. & A.C. Collins. 1989. Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacol. Biochem. Behav. 33: 469-475.
212. Villaneuva, H.F. et al. 1990. Withdrawal from nicotine fails to produce a conditioned taste aversion to saccharine in rats and mice. NIDA Res. Monogr. 105: 433-434.
213. Kenny, P.J. & A. Markou. 2005. Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems. J. Neurosci. 25: 6208-6212.
214. Grieder, T.E. et al. 2010. Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine. Neuropsychopharmacol. 35: 943-954.
215. Solomon, R.L. & J.D. Corbit. 1974. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol. Rev. 81: 119-145.
216. Scott, D. & N. Hiroi. 2010. Emergence of dormant conditioned incentive approach by conditioned withdrawal in nicotine addiction. Biol. Psychiatry 68: 726-732.
217. Heath, C.J., N.K. Horst & M.R. Picciotto. 2010. Oral nicotine consumption does not affect maternal care or early development in mice but results in modest hyperactivity in adolescence. Physiol. Behav. 101: 764-769.
218. Kota, D., B.R. Martin & M.I. Damaj. 2008. Age-dependent differences in nicotine reward and withdrawal in female mice. Psychopharmacology (Berl). 198: 201-210.
219. Kota, D. et al. 2007. Nicotine dependence and reward differ between adolescent and adult male mice. J. Pharmacol. Exp. Ther. 322: 399-407.
220. Lederle, L. et al. 2011. Reward-related behavioral paradigms for addiction research in the mouse: performance of common inbred strains. PLoS One 6: e15536.
221. Soria, G. et al. 2008. A reliable method to study cue-, priming-, and stress-induced reinstatement of cocaine self-administration in mice. Psychopharmacology (Berl). 199: 593-603.
222. Hogarth, L. & H.W. Chase. 2011. Parallel goal-directed and habitual control of human drug-seeking: implications for dependence vulnerability. J. Exp. Psychol. Anim. Behav. Process 37: 261-276.
223. Martin-Garcia, E. et al. 2009. New operant model of nicotine-seeking behaviour in mice. Int. J. Neuropsychopharmacol. 12: 343-356.
224. Kenney, J.W. & T.J. Gould. 2008. Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol. Neurobiol. 38: 101-121.
225. Tang, J. & J.A. Dani. 2009. Dopamine enables in vivo synaptic plasticity associated with the addictive drug nicotine. Neuron 63: 673-682.
226. Zhang, T.A. et al. 2010. Addictive nicotine alters local circuit inhibition during the induction of in vivo hippocampal synaptic potentiation. J. Neurosci. 30: 6443-6453.
227. Moragrega, I. et al. 2003. Spatial learning in male mice with different levels of aggressiveness: effects of housing conditions and nicotine administration. Behav. Brain Res. 147: 1-8.
228. Bernal, M.C. et al. 1999. Effects of nicotine on spatial learning in C57BL mice. Behav. Pharmacol. 10: 333-336.
229. Vicens, P., M.C. Carrasco & R. Redolat. 2003. Effects of early training and nicotine treatment on the performance of male NMRI mice in the water maze. Neural Plast. 10: 303-317.
230. Weiss, S. et al. 2007. Nicotine improves cognitive deficits of dopamine transporter knockout mice without long-term tolerance. Neuropsychopharmacol. 32: 2465-2478.
231. Gould, T.J. & J.M. Wehner. 1999. Nicotine enhancement of contextual fear conditioning. Behav. Brain Res. 102: 31-39.
232. Gould, T.J. & J.A. Lommock. 2003. Nicotine enhances contextual fear conditioning and ameliorates ethanol-induced deficits in contextual fear conditioning. Behav. Neurosci. 117: 1276-1282.
233. Gould, T.J. 2003. Nicotine produces a within-subject enhancement of contextual fear conditioning in C57BL/6 mice independent of sex. Integr. Physiol. Behav. Sci. 38: 124-132.
234. Gould, T.J. & J.S. Higgins. 2003. Nicotine enhances contextual fear conditioning in C57BL/6J mice at 1 and 7 days post-training. Neurobiol. Learn Mem. 80: 147-157.
235. Wehner, J.M. et al. 2004. Role of neuronal nicotinic receptors in the effects of nicotine and ethanol on contextual fear conditioning. Neuroscience 129: 11-24.
236. Davis, J.A., J. Porter & T.J. Gould. 2006. Nicotine enhances both foreground and background contextual fear conditioning. Neurosci. Lett. 394: 202-205.
237. Davis, J.A. et al. 2005. Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice. J. Neurosci. 25: 8708-8713.
238. Davis, J.A. & T.J. Gould. 2006. The effects of DHBE and MLA on nicotine-induced enhancement of contextual fear conditioning in C57BL/6 mice. Psychopharmacology (Berl). 184: 345-352.
239. Gulick, D. & T.J. Gould. 2008. Interactive effects of ethanol and nicotine on learning in C57BL/6J mice depend on both dose and duration of treatment. Psychopharmacology (Berl). 196: 483-495.
240. Davis, J.A., J.W. Kenney & T.J. Gould. 2007. Hippocampal α4β2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning. J. Neurosci. 27: 10870-10877.
241. Raybuck, J.D. & T.J. Gould. 2007. Extracellular signal-regulated kinase 1/2 involvement in the enhancement of contextual fear conditioning by nicotine. Behav. Neurosci. 121: 1119-1124.
242. Gould, T.J., O. Feiro & D. Moore. 2004. Nicotine enhances trace cued fear conditioning but not delay cued fear conditioning in C57BL/6 mice. Behav. Brain Res. 155: 167-173.
243. Raybuck, J.D. & T.J. Gould. 2009. Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice-a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors. Eur. J. Neurosci. 29: 377-387.
244. McEchron, M.D. et al. 1998. Hippocampectomy disrupts auditory trace fear conditioning and contextual fear conditioning in the rat. Hippocampus 8: 638-646.
245. Gulick, D. & T.J. Gould. 2009. The hippocampus and cingulate cortex differentially mediate the effects of nicotine on learning versus on ethanol-induced learning deficits through different effects at nicotinic receptors. Neuropsychopharmacol. 34: 2167-2179.
246. Raybuck, J.D. & T.J. Gould. 2010. The role of nicotinic acetylcholine receptors in the medial prefrontal cortex and hippocampus in trace fear conditioning. Neurobiol. Learn Mem. 94: 353-363.
247. Davis, J.A. & T.J. Gould. 2009. Hippocampal nAChRs mediate nicotine withdrawal-related learning deficits. Eur. Neuropsychopharmacol. 19: 551-561.
248. Picciotto, M.R. et al. 1995. Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain. Nature 374: 65-67.
249. Kenney, J.W. & T.J. Gould. 2008. Nicotine enhances context learning but not context-shock associative learning. Behav. Neurosci. 122: 1158-1165.
250. Bovet-Nitti, F. 1969. Facilitation of simultaneous visual discrimination by nicotine in four "inbred" strains of mice. Psychopharmacologia 14: 193-199.
251. Castellano, C. 1976. Effects of nicotine on discrimination learning, consolidation and learned behaviour in two inbred strains of mice. Psychopharmacology (Berl). 48: 37-43.
252. Bovet, D., F. Bovet-Nitti & A. Oliverio. 1966. Effects of nicotine on avoidance conditioning of inbred strains of mice. Psychopharmacologia 10: 1-5.
253. Ciamei, A. et al. 2001. Effects of MK-801 and nicotine combinations on memory consolidation in CD1 mice. Psychopharmacology (Berl). 154: 126-130.
254. Brioni, J.D. & S.P. Arneric. 1993. Nicotinic receptor agonists facilitate retention of avoidance training: participation of dopaminergic mechanisms. Behav. Neural Biol. 59: 57-62.
255. Feuerbach, D. et al. 2009. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology 56: 254-263.
256. Oliverio, A. 1968. Effects of nicotine and strychnine on transfer of avoidance learning in the mouse. Life Sci. 7: 1163-1167.
257. Biala, G. & M. Kruk. 2008. Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze test in mice. Behav. Brain Res. 192: 198-202.
258. Paylor, R. et al. 1998. α7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem. 5: 302-316.
259. Ren, K. et al. 2007. α7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation. Neuroscience 145: 314-322.
260. Meguro, K. et al. 1994. Nicotine improves cognitive disturbance in senescence-accelerated mice. Pharmacol. Biochem. Behav. 49: 769-772.
261. Bontempi, B. et al. 2003. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors. Neuropsychopharmacol. 28: 1235-1246.
262. Gulick, D. & T.J. Gould. 2010. Nicotine acts in the anterior cingulate, but not dorsal or ventral hippocampus, to reverse ethanol-induced learning impairments in the plus-maze discriminative avoidance task. Addict. Biol. 16: 176-188.
263. Mizoguchi, H. et al. 2011. Nicotine ameliorates impairment of working memory in methamphetamine-treated rats. Behav. Brain Res. 220: 159-163.
264. Rezayof, A. et al. 2010. Nicotine improves ethanol-induced memory impairment: the role of dorsal hippocampal NMDA receptors. Life Sci. 86: 260-266.
265. Decker, M.W. et al. 1994. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl)isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization. J. Pharmacol. Exp. Ther. 270: 319-328.
266. Obinu, M.C. et al. 2002. Brain-selective stimulation of nicotinic receptors by TC-1734 enhances ACh transmission from frontoparietal cortex and memory in rodents. Prog. Neuropsychopharmacol Biol. Psychiatry 26: 913-918.
267. Gatto, G.J. et al. 2004. TC-1734: an orally active neuronal nicotinic acetylcholine receptor modulator with antidepressant, neuroprotective and long-lasting cognitive effects. CNS Drug Rev. 10: 147-166.
268. Rueter, L.E. et al. 2004. ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disorders. CNS Drug Rev. 10: 167-182.
269. Boess, F.G. et al. 2007. The novel α7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2] oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents. J. Pharmacol. Exp. Ther. 321: 716-725.
270. Gulick, D. & T.J. Gould. 2008. Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice. Neurobiol. Learn Mem. 90: 230-236.
271. Azizbeigi, R. et al. 2011. Nicotine restores morphine-induced memory deficit through the D1 and D2 dopamine receptor mechanisms in the nucleus accumbens. J. Psychopharmacol. 25: 1126-1133.
272. Andre, J.M., P.T. Leach & T.J. Gould. 2011. Nicotine ameliorates NMDA receptor antagonist-induced deficits in contextual fear conditioning through high-affinity nicotinic acetylcholine receptors in the hippocampus. Neuropharmacology 60: 617-625.
273. Young, J.W. et al. 2007. The odour span task: a novel paradigm for assessing working memory in mice. Neuropharmacology 52: 634-645.
274. Valzelli, L., G. Baiguerra & O. Giraud. 1986. Difference in learning and retention by Albino Swiss mice. Part III. Effect of some brain stimulants. Methods Find Exp. Clin. Pharmacol. 8: 337-341.
275. Zarrindast, M.R., M. Sadegh & B. Shafaghi. 1996. Effects of nicotine on memory retrieval in mice. Eur. J. Pharmacol. 295: 1-6.
276. Andreasen, J.T. et al. 2011. Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline. J. Psychopharmacol. 25: 1134-1141.
277. Beer, A. et al. 2005. Nicotine therapy in adulthood reverses the synaptic and behavioral deficits elicited by prenatal exposure to phenobarbital. Neuropsychopharmacol. 30: 156-165.
278. Portugal, G.S., J.W. Kenney & T.J. Gould. 2008. α2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning. Neurobiol. Learn Mem. 89: 106-113.
279. Portugal, G.S. & T.J. Gould. 2009. Nicotine withdrawal disrupts new contextual learning. Pharmacol. Biochem. Behav. 92: 117-123.
280. Portugal, G.S. & T.J. Gould. 2007. Bupropion dose-dependently reverses nicotine withdrawal deficits in contextual fear conditioning. Pharmacol. Biochem. Behav. 88: 179-187.
281. Raybuck, J.D. et al. 2008. Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. Behav. Neurosci. 122: 1166-1171.
282. Wilkinson, D.S. & T.J. Gould. 2011. The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice. Behav. Brain Res. 223: 53-57.
283. Davis, J.A. & T.J. Gould. 2007. Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning. Neuropsychopharmacol. 32: 2011-2019.
284. Humby, T. et al. 1999. Visuospatial attentional functioning in mice: interactions between cholinergic manipulations and genotype. Eur. J. Neurosci. 11: 2813-2823.
285. Patel, S. et al. 2006. Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task. Behav. Brain Res. 170: 197-203.
286. Pattij, T. et al. 2007. Strain specificity and cholinergic modulation of visuospatial attention in three inbred mouse strains. Genes Brain Behav. 6: 579-587.
287. Bailey, C.D. et al. 2010. The nicotinic acetylcholine receptor α5 subunit plays a key role in attention circuitry and accuracy. J. Neurosci. 30: 9241-9252.
288. de Bruin, N.M. et al. 2006. Attentional performance of (C57BL/6Jx129Sv)F2 mice in the five-choice serial reaction time task. Physiol. Behav. 89: 692-703.
289. Young, J.W. et al. 2004. Nicotine improves sustained attention in mice: evidence for involvement of the α7 nicotinic acetylcholine receptor. Neuropsychopharmacol. 29: 891-900.
290. Hoyle, E. et al. 2006. Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task. Psychopharmacology (Berl). 189: 211-223.
291. Levin, E.D. & A.H. Rezvani. 2007. Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function. Biochem. Pharmacol. 74: 1182-1191.
292. Mexal, S. et al. 2007. α7 nicotinic receptor gene promoter polymorphisms in inbred mice affect expression in a cell type-specific fashion. J. Biol. Chem. 282: 13220-13227.
293. Stevens, K.E. et al. 1996. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacol. 15: 152-162.
294. Fernandes, C. et al. 2006. Performance deficit of α7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory. Genes Brain Behav. 5: 433-440.
295. Granon, S., P. Faure & J.P. Changeux. 2003. Executive and social behaviors under nicotinic receptor regulation. Proc. Natl. Acad. Sci. U. S. A. 100: 9596-9601.
296. Stevens, K.E. et al. 1998. Selective α7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl). 136: 320-327.
297. Gould, T.J., M. Rukstalis & M.C. Lewis. 2005. Atomoxetine and nicotine enhance prepulse inhibition of acoustic startle in C57BL/6 mice. Neurosci. Lett. 377: 85-90.
298. Rollema, H. et al. 2009. Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition. Biochem. Pharmacol. 78: 813-824.
299. Semenova, S., A. Bespalov & A. Markou. 2003. Decreased prepulse inhibition during nicotine withdrawal in DBA/2J mice is reversed by nicotine self-administration. Eur. J. Pharmacol. 472: 99-110.
300. Kumari, V. & J.A. Gray. 1999. Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex. Psychopharmacology (Berl). 141: 11-15.
301. Andre, J.M. et al. 2008. Nicotine withdrawal disrupts both foreground and background contextual fear conditioning but not pre-pulse inhibition of the acoustic startle response in C57BL/6 mice. Behav. Brain Res. 190: 174-181.
302. Bilkei-Gorzo, A. et al. 2008. A common genetic predisposition to stress sensitivity and stress-induced nicotine craving. Biol. Psychiatry 63: 164-171.
303. Elias, G.A. et al. 2010. Nicotine and extinction of fear conditioning. Neuroscience 165: 1063-1073.
304. Ito, R. & M. Canseliet. 2010. Amphetamine exposure selectively enhances hippocampus-dependent spatial learning and attenuates amygdala-dependent cue learning. Neuropsychopharmacol. 35: 1440-1452.
305. Grimm, J.W. et al. 2001. Neuroadaptation. Incubation of cocaine craving after withdrawal. Nature 412: 141-142.
306. Abdolahi, A. et al. 2010. Incubation of nicotine seeking is associated with enhanced protein kinase A-regulated signaling of dopamine- and cAMP-regulated phosphoprotein of 32 kDa in the insular cortex. Eur. J. Neurosci. 31: 733-741.
307. Bedi, G. et al. 2011. Incubation of cue-induced cigarette craving during abstinence in human smokers. Biol. Psychiatry 69: 708-711.
308. Sorge, R.E., H. Rajabi & J. Stewart. 2005. Rats maintained chronically on buprenorphine show reduced heroin and cocaine seeking in tests of extinction and drug-induced reinstatement. Neuropsychopharmacol. 30: 1681-1692.
309. Lee, J.L., A.L. Milton & B.J. Everitt. 2006. Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsolidation. J. Neurosci. 26: 5881-5887.
310. Pickens, C.L., B.M. Navarre & S.G. Nair. 2010. Incubation of conditioned fear in the conditioned suppression model in rats: role of food-restriction conditions, length of conditioned stimulus, and generality to conditioned freezing. Neuroscience 169: 1501-1510.
311. Mead, A.N. et al. 2007. AMPA-receptor GluR1 subunits are involved in the control over behavior by cocaine-paired cues. Neuropsychopharmacol. 32: 343-353.
312. Biala, G. & B. Weglinska. 2005. Blockade of the expression of mecamylamine-precipitated nicotine withdrawal by calcium channel antagonists. Pharmacol. Res. 51: 483-488.
313. Hur, Y.N. et al. 2010. High fat diet altered the mechanism of energy homeostasis induced by nicotine and withdrawal in C57BL/6 mice. Mol. Cells 30: 219-226.
314. Balerio, G.N., E. Aso & R. Maldonado. 2005. Involvement of the opioid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl). 181: 260-269.
315. Balerio, G.N., E. Aso & R. Maldonado. 2006. Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl). 184: 504-513.
316. Zarrindast, M.R. et al. 2000. Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. Eur. J. Pharmacol. 407: 145-158.
317. Kayir, H. & I.T. Uzbay. 2006. Nicotine antagonizes caffeine- but not pentylenetetrazole-induced anxiogenic effect in mice. Psychopharmacology (Berl). 184: 464-469.
318. Booker, T.K. et al. 2007. Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice. Pharmacol. Biochem. Behav. 87: 146-157.
319. Salas, R. et al. 2003. Altered anxiety-related responses in mutant mice lacking the β subunit of the nicotinic receptor. J. Neurosci. 23: 6255-6263.
320. Vinkers, C.H. et al. 2009. Stress-induced hyperthermia is reduced by rapid-acting anxiolytic drugs independent of injection stress in rats. Pharmacol. Biochem. Behav. 93: 413-418.
321. Abreu-Villaca, Y. et al. 2006. Individual differences in novelty-seeking behavior but not in anxiety response to a new environment can predict nicotine consumption in adolescent C57BL/6 mice. Behav. Brain Res. 167: 175-182.
322. Manhaes, A.C. et al. 2008. Anxiety-like behavior during nicotine withdrawal predict subsequent nicotine consumption in adolescent C57BL/6 mice. Behav. Brain Res. 193: 216-224.
323. Hunter, R.G. et al. 2010. Regulation of the nicotinic receptor alpha7 subunit by chronic stress and corticosteroids. Brain Res. 1325: 141-146.
324. Hayase, T. 2011. Depression-related anhedonic behaviors caused by immobilization stress: a comparison with nicotine-induced depression-like behavioral alterations and effects of nicotine and/or "antidepressant" drugs. J. Toxicol. Sci. 36: 31-41.
325. Salas, R. & M. De Biasi. 2008. Opposing actions of chronic stress and chronic nicotine on striatal function in mice. Neurosci. Lett. 440: 32-34.
326. Caldarone, B.J., S.L. King & M.R. Picciotto. 2008. Sex differences in anxiety-like behavior and locomotor activity following chronic nicotine exposure in mice. Neurosci. Lett. 439: 187-191.
327. Wing, V.C. et al. 2009. Measurement of affective state during chronic nicotine treatment and withdrawal by affective taste reactivity in mice: the role of endocannabinoids. Biochem. Pharmacol. 78: 825-835.
328. Jackson, K.J. et al. 2009. The role of various nicotinic receptor subunits and factors influencing nicotine conditioned place aversion. Neuropharmacology 56: 970-974.
329. Pinkston, J.W. & R.J. Lamb. 2011. Delay discounting in C57BL/6J and DBA/2J mice: adolescent-limited and life-persistent patterns of impulsivity. Behav. Neurosci. 125: 194-201.